Send me a link:

*Text messaging rates may apply.

 Dow Down 0.42% Nasdaq Down 0.39%

Novavax, Inc. (NVAX)

-NasdaqGS
4.27 Down 0.07(1.61%) 4:00PM EDT
Prev Close:4.34
Open:4.33
Bid:4.27 x 800
Ask:4.28 x 5000
1y Target Est:11.00
Beta:1.17
Next Earnings Date: 6-Aug-14NVAX Earnings announcement
Day's Range:4.19 - 4.38
52wk Range:2.24 - 6.95
Volume:2,507,674
Avg Vol (3m):3,924,920
Market Cap:893.45M
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NVAX

Comparison

Symbol% ChgMkt Cap
NVAXDown 1.61%893.45M
MRKUp 0.11%165.99B
NVSDown 0.05%210.84B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):37.00
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.27
Quarterly EPS Est (Jun-14) :-0.07
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback